Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached

Novo Nordisk reveals cyberattack: Ozempic and Wegovy maker says clinical trials data breached | Daily Reports Online

Share


  • Novo Nordisk cyberattack exposed pseudonymized clinical trial patient data (IDs, biomarkers, lifestyle factors)
  • Company insists no direct PII was leaked, reducing immediate risk of phishing or identity misuse
  • Systems shut down for containment; third‑party experts investigating, core operations remain unaffected

Novo Nordisk, one of the biggest pharmaceutical companies in the world, has confirmed it recently suffered a cyberattack in which it lost sensitive data belonging to clinical trials patients.


The company claims the data is pseudonymized and as such cannot be used in phishing scams or other follow-up attacks.


Similar Posts